HIV Viral Load Non-suppression and Associated Factors Among Pregnant and Postpartum Women in Rural Northeastern South Africa: a Cross-sectional Survey

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Mar 11

PMID 35273061

Authors

Nobubelo Kwanele Ngandu

Carl J Lombard

Thandiwe Elsie Mbira

Adrian Puren

Catriona Waitt

Andrew J Prendergast

Thorkild Tylleskar

Philippe Van de Perre

Ameena Ebrahim Goga

Affiliations

Soon will be listed here.

Abstract

Objectives: We aimed to measure the prevalence of maternal HIV viral load (VL) non-suppression and assess associated factors, to evaluate progress towards United Nations-AIDS (UNAIDS) targets.

Design: Cross-sectional study.

Setting: The eight largest community health centres of Ehlanzeni, a rural district in northeast South Africa.

Participants: Pregnant women living with HIV (WLHIV) in their third trimester and postpartum WLHIV and their biological infants, recruited equally across all stages of the first 24 months post partum, were included. A sample of 612 mothers participated from a target of 1000.

Primary Outcome Measures: The primary outcome was maternal VL (mVL) non-suppression (defined here as mVL >1000 copies/mL). We collected information on antiretroviral use, healthcare visits and sociodemographics through interviews and measured plasma mVL. Descriptive statistics, χ tests and multivariable logistic regression analysis were conducted.

Results: All mothers (median age: 30 years) were on antiretroviral therapy (ART) and 24.9% were on ART ≤12 months. The prevalence of mVL non-suppression was 14.7% (95% CI: 11.3% to 19.0%), while 13.8% had low-level viraemia (50-1000 copies/mL). Most (68.9%) women had initiated breast feeding and 37.6% were currently breast feeding their infants. Being younger than 25 years (adjusted odds ratio (AOR): 2.6 (95% CI: 1.1 to 6.4)), on first-line ART (AOR: 2.3 (95% CI: 1.1 to 4.6)) and married/cohabiting (AOR: 1.9 (95% CI: 1.0 to 3.7)) were significantly associated with increased odds of mVL non-suppression.

Conclusions: The prevalence of mVL ≤1000 copies/mL of 85.3% among pregnant and postpartum WLHIV and attending public healthcare centres in this rural district is below the 2020 90-90-90 and 2030 95-95-95 UNAIDS targets. Given that low-level viraemia may also increase the risk of vertical HIV transmission, we recommend strengthened implementation of the new guidelines which include better ART options, improved ART regimen switching and mVL monitoring schedules, and intensified psychosocial support for younger women, while exploring district-level complementary interventions, to sustain VLs below 50 copies/mL among all women.

Citing Articles

Human Immunodeficiency Virus (HIV) viral load suppression status and associated factors among pregnant women receiving Highly Active Antiretroviral Therapy (HAART) in Ethiopia.

Hailu G, Keraleme A, Zealiyas K, Tesema A, Nuramed N, Girmachew F Virol J. 2025; 22(1):49.

PMID: 40001227 PMC: 11853537. DOI: 10.1186/s12985-025-02659-0.

"I desire to have an HIV-free baby": pregnant and breastfeeding mothers' perceptions of Viral load testing and suppression in HIV care in southwestern Uganda.

Kabami J, Akatukwasa C, Kabageni S, Nangendo J, Byamukama A, Atwiine F Discov Soc Sci Health. 2024; 4(1):60.

PMID: 39524078 PMC: 11541329. DOI: 10.1007/s44155-024-00120-1.

Sexually transmitted infections and bacterial vaginosis among adolescent girls and young women in the early postpartum period: a cross-sectional study.

Govender V, Naidoo M, Moodley D BMC Infect Dis. 2024; 24(1):898.

PMID: 39223449 PMC: 11367844. DOI: 10.1186/s12879-024-09781-4.

Antiretroviral therapy retention, adherence, and clinical outcomes among postpartum women with HIV in Nigeria.

Young C, Chang C, Sagay A, Imade G, Ogunsola O, Okonkwo P PLoS One. 2024; 19(8):e0302920.

PMID: 39110750 PMC: 11305526. DOI: 10.1371/journal.pone.0302920.

Forgetting to Take Medication, Treatment Adherence and Their Relationship with Viral Load Suppression Among People Living with HIV in the Kilimanjaro Region, Tanzania.

Masika L, Mboya I, Maro R, Mtesha B, Mtoro M, Ngowi K HIV AIDS (Auckl). 2024; 16:245-257.

PMID: 38911143 PMC: 11192192. DOI: 10.2147/HIV.S452875.

References

Ramlagan S, Peltzer K, Ruiter R, Barylski N, Weiss S, Sifunda S . Prevalence and Factors Associated with Fixed-Dose Combination Antiretroviral Drugs Adherence among HIV-Positive Pregnant Women on Option B Treatment in Mpumalanga Province, South Africa. Int J Environ Res Public Health. 2018; 15(1). PMC: 5800260. DOI: 10.3390/ijerph15010161. View

Goga A, Lombard C, Jackson D, Ramokolo V, Ngandu N, Sherman G . Impact of breastfeeding, maternal antiretroviral treatment and health service factors on 18-month vertical transmission of HIV and HIV-free survival: results from a nationally representative HIV-exposed infant cohort, South Africa. J Epidemiol Community Health. 2020; 74(12):1069-1077. PMC: 11459440. DOI: 10.1136/jech-2019-213453. View

Technau K, Kalk E, Coovadia A, Black V, Pickerill S, Mellins C . Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2014; 65(5):e170-8. PMC: 3999509. DOI: 10.1097/QAI.0000000000000068. View

Clouse K, Schwartz S, Van Rie A, Bassett J, Yende N, Pettifor A . "What they wanted was to give birth; nothing else": barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014; 67(1):e12-8. PMC: 6686681. DOI: 10.1097/QAI.0000000000000263. View

Woldesenbet S, Kufa T, Barron P, Chirombo B, Cheyip M, Ayalew K . Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa. AIDS. 2019; 34(4):589-597. PMC: 7050794. DOI: 10.1097/QAD.0000000000002457. View

Bares S, Smeaton L, Xu A, Godfrey C, McComsey G . HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy. J Womens Health (Larchmt). 2018; 27(9):1162-1169. PMC: 6148723. DOI: 10.1089/jwh.2017.6717. View

Hodgson I, Plummer M, Konopka S, Colvin C, Jonas E, Albertini J . A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One. 2014; 9(11):e111421. PMC: 4221025. DOI: 10.1371/journal.pone.0111421. View

Kintu K, Malaba T, Nakibuka J, Papamichael C, Colbers A, Byrne K . Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial. Lancet HIV. 2020; 7(5):e332-e339. PMC: 10877544. DOI: 10.1016/S2352-3018(20)30050-3. View

Blashill A, Mayer K, Crane H, Grasso C, Safren S . Body mass index, immune status, and virological control in HIV-infected men who have sex with men. J Int Assoc Provid AIDS Care. 2013; 12(5):319-24. PMC: 4259246. DOI: 10.1177/2325957413488182. View

10.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

11.

Hopkins K, Laher F, Otwombe K, Churchyard G, Bekker L, DeRosa S . Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses. PLoS One. 2014; 9(8):e103446. PMC: 4121165. DOI: 10.1371/journal.pone.0103446. View

12.

Drain P, Dorward J, Bender A, Lillis L, Marinucci F, Sacks J . Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response. Clin Microbiol Rev. 2019; 32(3). PMC: 6589862. DOI: 10.1128/CMR.00097-18. View

13.

Fatti G, Shaikh N, Eley B, Jackson D, Grimwood A . Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: A cohort study at public facilities in the Nelson Mandela Bay Metropolitan district, Eastern Cape, South.... S Afr Med J. 2015; 104(12):874-80. DOI: 10.7196/samj.8207. View

14.

Vrazo A, Firth J, Amzel A, Sedillo R, Ryan J, Phelps B . Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review. Trop Med Int Health. 2017; 23(2):136-148. DOI: 10.1111/tmi.13014. View

15.

Myer L, Dunning L, Lesosky M, Hsiao N, Phillips T, Petro G . Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study. Clin Infect Dis. 2016; 64(4):422-427. PMC: 5849096. DOI: 10.1093/cid/ciw792. View

16.

Ashaba S, Kaida A, Coleman J, Burns B, Dunkley E, ONeil K . Psychosocial challenges facing women living with HIV during the perinatal period in rural Uganda. PLoS One. 2017; 12(5):e0176256. PMC: 5411062. DOI: 10.1371/journal.pone.0176256. View

17.

Glass T, Motaboli L, Nsakala B, Lerotholi M, Vanobberghen F, Amstutz A . The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho. PLoS One. 2019; 14(8):e0220337. PMC: 6713472. DOI: 10.1371/journal.pone.0220337. View

18.

Muchedzi A, Chandisarewa W, Keatinge J, Stranix-Chibanda L, Woelk G, Mbizvo E . Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe. J Int AIDS Soc. 2010; 13:38. PMC: 2978127. DOI: 10.1186/1758-2652-13-38. View

19.

Siedner M, Moorhouse M, Simmons B, de Oliveira T, Lessells R, Giandhari J . Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nat Commun. 2020; 11(1):5922. PMC: 7708638. DOI: 10.1038/s41467-020-19801-x. View

20.

Bvochora T, Satyanarayana S, Takarinda K, Bara H, Chonzi P, Komtenza B . Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues. PLoS One. 2019; 14(2):e0211326. PMC: 6363281. DOI: 10.1371/journal.pone.0211326. View